✦ LIBER ✦

Re: Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 Status

✍ Scribed by Wood, David P.

Book ID: 118484943
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 91 KB
Volume: 187
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2012.02.2550

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Phase III Study of Molecularly Targe

Re: Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 Status

✍ William M. Hilton; Robert S. Svatek 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Re: Phase III Study of Molecularly Targe

Re: Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 Status

✍ Thomas W. Flaig; Dan Theodorescu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views